Neuropharmacology of Cannabinoids: A Comprehensive Review of Preclinical and Clinical Evidence for Hemp-Derived Extracts and Active Compounds.

Odonkor CA, Karpe DA, Siddique MU, Abd-Elsayed A

Open source

DOI
10.3390/ph19081151
Published
2026 Jul 24
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19081151,
  title = {Neuropharmacology of Cannabinoids: A Comprehensive Review of Preclinical and Clinical Evidence for Hemp-Derived Extracts and Active Compounds.},
  author = {Odonkor CA and Karpe DA and Siddique MU and Abd-Elsayed A},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19081151},
  url = {https://doi.org/10.3390/ph19081151}
}

RIS

TY  - JOUR
TI  - Neuropharmacology of Cannabinoids: A Comprehensive Review of Preclinical and Clinical Evidence for Hemp-Derived Extracts and Active Compounds.
AU  - Odonkor CA
AU  - Karpe DA
AU  - Siddique MU
AU  - Abd-Elsayed A
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19081151
UR  - https://doi.org/10.3390/ph19081151
ER  - 

APA

CA, O., DA, K., MU, S., & A, A. (2026). Neuropharmacology of Cannabinoids: A Comprehensive Review of Preclinical and Clinical Evidence for Hemp-Derived Extracts and Active Compounds.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19081151

Source records